Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin

BACKGROUND: Small studies have suggested that nucleos(t)ide analogue therapy (NAT) with reduced hepatitis B immunoglobulin (HBIG) duration may be efficacious in preventing post-liver transplantation (LT) HBV recurrence. OBJECTIVES: This larger study evaluates the use of NAT with short term (< 6 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Joseph, Cohen, Stanley Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227486/
https://www.ncbi.nlm.nih.gov/pubmed/22140388
http://dx.doi.org/10.5812/kowsar.1735143X.717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227486/
https://www.ncbi.nlm.nih.gov/pubmed/22140388
http://dx.doi.org/10.5812/kowsar.1735143X.717

Ejemplares similares